VVOS
Vivos Therapeutics, Inc. Common Stock
Nasdaq · usd
Vivos Therapeutics, Inc. Common Stock (VVOS) trades at $0.1299 (-2.84%) as of 2:06:20 PM EDT on Oct 26, 2026, -7.68% over the past month. Market cap is $2.69M, with 1.0 days to cover in short interest.
Stock performance
How Vivos Therapeutics, Inc. Common Stock (VVOS) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.84%
- 1W
- -3.71%
- 1M
- -7.68%
- YTD
- -93.60%
- 1Y
- -95.22%
- 52-wk range
- $0.12 – $3.05
Key statistics
Today's trading snapshot for VVOS: day range, open, previous close, volume and market cap.
- Day range
- $0.12 – $0.13
- Open
- $0.13
- Prev close
- $0.13
- Volume
- 376.65K
- Market cap
- $2.69M
- Shares out
- 13.89M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Vivos Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 0.13
- P/B
- -0.69
- P/FCF
- —
- ROE
- 667.3%
- ROA
- -105.4%
- Debt/Equity
- -2.17
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Vivos Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Listing compliance regainedOct 21, 2026
On October 20, 2026, the Company received a letter from the Staff stating that, based on the Company's Current Report on Form 8-K filed October 19, 2026, the Staff has determined that the Company complies with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1).
- Listing deficiency noticeOct 19, 2026
On April 22, 2026, the Company received a notice from the Listing Qualifications staff of The Nasdaq Stock Market LLC ... indicating that the Company did not satisfy the minimum stockholders' equity requirement of $2,500,000 for continued listing.
- Acquisition consideration sharesOct 15, 2026
At the Closing, the Company will issue to SOD 12,000 shares of a newly created series of the Company's preferred stock ... with an aggregate stated value of $12,000,000, in exchange for ... 2,907,338 shares of SOD common stock ... and ... a fifty percent (50%) co-ownership interest in the Test and related intellectual property.
- Going concernOct 1, 2026
Baker Tilly's report on the Company's consolidated financial statements as of and for the fiscal year ended December 31, 2025, and Moss Adams' report ... for the fiscal year ended December 31, 2024, ... included explanatory paragraphs expressing substantial doubt regarding the Company's ability to continue as a going concern.
- Debt retirementSep 8, 2026
Pursuant to the Exchange Agreements, the Company and Streeterville partitioned an aggregate of $2,861,270.00 of the outstanding principal balance of the Streeterville Note into twelve (12) separate secured promissory notes... Streeterville agreed to surrender each Partitioned Note to the Company in exchange for the issuance... of up to 11,445,080 shares of Common Stock.
Dividend history and stock splits
Vivos Therapeutics, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-25Oct 27, 2023
VVOS short interest
How heavily VVOS is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 2.86M
- Avg volume
- 8.03M
As of · reported to FINRA twice monthly.
VVOS news
The latest news and headlines about Vivos Therapeutics, Inc. Common Stock (VVOS).
- Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine CenterspositiveGlobeNewswire Inc.· Aug 25, 2026
- Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026neutralGlobeNewswire Inc.· Jun 8, 2026
- Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsightpositiveGlobeNewswire Inc.· Jan 21, 2026
- Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross ProceedsneutralGlobeNewswire Inc.· Jan 20, 2026
- Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am ESTpositiveGlobeNewswire Inc.· Dec 15, 2025
Frequently asked questions
What is the Vivos Therapeutics, Inc. Common Stock (VVOS) stock price today?
Vivos Therapeutics, Inc. Common Stock (VVOS) is trading at $0.1299 (-2.84% on the day) as of 2:06:20 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Vivos Therapeutics, Inc. Common Stock?
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including…
What is the short interest in VVOS?
As of Sep 30, 2026, VVOS has 2.86M shares short and 1.0 days to cover.
What exchange is VVOS listed on?
Vivos Therapeutics, Inc. Common Stock (VVOS) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of VVOS with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a VVOS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.